Insider Transactions in Q2 2023 at Coherus Bio Sciences, Inc. (CHRS)
Insider Transaction List (Q2 2023)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Apr 01
2023
|
Mc David Stilwell Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,457
-3.27%
|
$20,742
$6.84 P/Share
|
Apr 01
2023
|
Paul Reider Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,451
-2.74%
|
$14,706
$6.84 P/Share
|